Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Study on Tirofiban With Aspirin in the Treatment of Acute Penetrating Artery Territory Infarction (STRATEGY)

NCT05310968 is registered in ClinicalTrials.gov with Beijing Tiantan Hospital as lead sponsor.

NCT NCT05310968
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05310968 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Study on Tirofiban With Aspirin in the Treatment of Acute Penetrating Artery Territory Infarction (STRATEGY)
Lead sponsor
Beijing Tiantan Hospital
Phase
Phase 4
Overall status
Completed
Start date
November 12, 2022
Completion date
September 1, 2025
Enrollment
970 (actual)
Sites
37

Conditions

As the registry lists them; a condition with its own page is linked.

branch atheromatous disease